Mutations in the tumor suppressor Cux1 and RNA splicing factor mutations are associated with MDS/MPD, while strong selection for mutations activating Ras/Raf/MAPK signaling are invariably associated with progression to MPD. The gene discussed is CUX1; the disease is myelodysplastic syndrome.